Clinical trial participant – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Sat, 30 May 2026 04:03:41 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Clinical trial participant – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 A Study of Cannabidiol for Sleep Quality After Evening Exercise in Healthy People https://clinicaltrials.eu/trial/a-study-of-cannabidiol-for-sleep-quality-after-evening-exercise-in-healthy-people/ Wed, 29 Apr 2026 15:08:42 +0000 https://clinicaltrials.eu/trial/a-study-of-cannabidiol-for-sleep-quality-after-evening-exercise-in-healthy-people/ This study is looking at healthy individuals who exercise regularly. The study will use Cannabidiol, which is a substance derived from the cannabis plant, given in hard capsule form. Another product called Softisan 378, which is a non-oxidizing fat base, will also be used in the study. Both products are taken by mouth.

The purpose of this study is to investigate the effect of Cannabidiol on sleep efficiency following late evening exercise. Sleep efficiency is a measure that compares the time spent actually sleeping to the total time spent in bed. The study will examine whether taking Cannabidiol affects how well people sleep after exercising late in the evening. The study will also look at other aspects of sleep quality, how people feel about their sleep, and measure certain hormones and chemical substances in the blood and urine that are related to sleep and stress.

During the study, participants will take part in different sessions where they will receive either Cannabidiol or Softisan 378. The maximum daily amount of Cannabidiol that can be given is 400 milligrams, while the maximum daily amount of Softisan 378 is 1200 milligrams. The study will measure changes in sleep patterns between the different sessions and collect blood and urine samples to analyze various substances that affect sleep. Participants will be healthy adults between 18 and 40 years old who exercise regularly and have good sleep quality to begin with.

]]> Study on How Minzasolmin is Absorbed in the Body and its Safety in Healthy Adults https://clinicaltrials.eu/trial/study-on-how-minzasolmin-is-absorbed-in-the-body-and-its-safety-in-healthy-adults/ Wed, 29 Apr 2026 15:05:28 +0000 https://clinicaltrials.eu/trial/study-on-how-minzasolmin-is-absorbed-in-the-body-and-its-safety-in-healthy-adults/ This clinical trial is focused on understanding how the body absorbs a medication called Minzasolmin when taken in different forms and how food might affect its absorption. The study involves healthy adults and aims to compare a new tablet form of Minzasolmin with an existing capsule form. The purpose is to estimate how much of the drug enters the bloodstream in these different forms and conditions.

Participants in the study will take Minzasolmin in both tablet and capsule forms. The study will observe how the drug is absorbed when taken on an empty stomach and after eating. This will help researchers understand the best way to take Minzasolmin for optimal absorption. The study will also monitor for any side effects that may occur during the trial.

The trial is designed to ensure the safety of participants while gathering important information about Minzasolmin. By comparing the different forms and conditions, researchers hope to determine the most effective way to administer the medication. The study will provide valuable insights into the drug’s behavior in the body, contributing to its safe and effective use in the future.

]]>